Atlas Trials

A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Clinical trial NCT02709109 · COMPLETED

Trial details

NCT number
NCT02709109
Sponsor
Parion Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2016-02-01
Primary completion
2017-09-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.